Should You Sell These Coronavirus Vaccine Stocks?

Shares of Moderna (NASDAQ: MRNA), Inovio (NASDAQ: INO), Novavax (NASDAQ: INO), and other companies in the race to develop a coronavirus vaccine have skyrocketed over the past several months, with investors betting on which company will reach the finish line first. As the coronavirus pandemic deepened, the U.S. government put forth a plan to help accelerate vaccine development. At the same time, companies have been pushing their vaccine candidates into human trials at record speed.